Nutriflex Omega Special Ohne Elektrolyte (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Valine, together with the other amino acids in the formulation, is delivered directly into the bloodstream where it becomes a building block for protein synthesis, supports gluconeogenesis, and helps maintain nitrogen balance. This rapid availability aids cellular repair and metabolic stability during periods of high physiological stress.

The prescribed dose is individualized by the treating clinician based on the patient’s weight, metabolic needs, and clinical condition. Healthcare professionals calculate the appropriate volume and infusion rate to meet the required amino‑acid intake while monitoring laboratory parameters.

Use in pregnancy or lactation should be considered only when clearly needed and prescribed by a qualified healthcare provider. The benefits of adequate nutrition must be weighed against any potential risks, and the product should be administered under close medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and necessary import documentation.

Nutriflex Omega Special Ohne Elektrolyte offers an electrolyte‑free amino‑acid profile, which can be advantageous when electrolyte balance is managed separately. Compared with other formulations that include electrolytes, this product allows clinicians greater flexibility to tailor electrolyte supplementation according to individual patient needs.

Store the product below 25 °C in its original packaging, protecting it from moisture and direct sunlight. Do not freeze. Before use, inspect the solution for particulate matter or discoloration and ensure aseptic technique during preparation and administration.

The solution is administered intravenously, typically via a central or peripheral venous catheter. It should be infused according to the prescribed rate, using compatible infusion sets, and monitored for signs of intolerance or adverse reactions throughout the administration period.

Serious risks include severe allergic reactions such as anaphylaxis, catheter‑related bloodstream infections, metabolic acidosis, and hepatic dysfunction with prolonged use. Prompt recognition and management of these events are essential, and patients should be closely monitored during therapy.

Patients with known hypersensitivity to any component of the formulation, those with uncontrolled metabolic disorders, or individuals with active severe infections where parenteral nutrition is contraindicated should not receive this product unless a risk‑benefit assessment justifies its use.